Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.
Mercy BioAnalytics has raised $59.0M in total funding. The most recent round was Series B. The last funding was announced in September 2025.
Mercy BioAnalytics's investors include Portfolia, Hologic, Hatteras Venture Partners, Sozo Ventures, LabCorp.
Mercy BioAnalytics is headquartered in Natick, United States.
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.
Mercy BioAnalytics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mercy BioAnalytics — Funding & Investors." VCBacked, September 3, 2025, https://www.vcbacked.co/company/mercy-bioanalytics. Accessed September 14, 2026.
VCBacked. (2025). Mercy BioAnalytics — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/mercy-bioanalytics
{{cite web |title=Mercy BioAnalytics — Funding & Investors |url=https://www.vcbacked.co/company/mercy-bioanalytics |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated